Skip to content
Guavy Logo GUAVY
Sign up
Back to Guavy Wire
Stocks

Merck KGaA Boosts 2026 Profit Outlook Amid Strong Q3 Earnings

Guavy AI Editorial Team
Instruments
MRK
Share

German life-sciences and materials group Merck KGaA has upgraded its 2026 profit forecast after delivering a strong quarterly earnings report. The company's adjusted EBITDA, a key profitability metric, is now expected to reach €5.9-€6.3 billion in 2026, up from an earlier estimate of €5.7-€6.1 billion.

This revised outlook comes as Merck continues to expand its Life Science unit through strategic acquisitions, including the recent $11.3 billion deal for US biotech tools company Bio-Techne.

The upgrade gives investors a more positive view on the combined group's financial health, making it less likely that lenders will scrutinize the Bio-Techne acquisition as a costly and risky move.

More on Stocks

Stocks 1m ago

P&G Buys Thorne in Record-Breaking Wellness Deal

Stocks 2m ago

Oracle Stock Struggles Amid AI Concerns and Balance Sheet Pressure

Stocks 2m ago

Amazon's AI Buildout at Risk as US Considers Optical Module Ban

Disclaimer: Guavy is a data and market intelligence provider, not an investment advisor. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Guavy Logo GUAVY

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

Navigate

Markets

Resources

© 2026 Guavy Inc

Terms Privacy Policy